Vimarsana
Biggest News Aggregation in the World

Daniel Stauder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Stauder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Stauder Today - Breaking & Trending Today

Avanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call Transcript - Vimarsana News

Avanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call Transcript

Operator: Good morning ladies and gentlemen and welcome to the Avanos First Quarter 2024 Earnings Conference. At this time, all lines are in a listen-only mode.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript - Vimarsana News

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript

LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc.

An atrial fibrillation device maker has 70% upside, JMP Securities says - Vimarsana News

An atrial fibrillation device maker has 70% upside, JMP Securities says

Analyst Daniel Stauder initiated coverage of the stock with an outperform rating and $60 price target, implying shares could soar by almost 70%.

Source: cnbc.com
Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates - Nevro (NYSE:NVRO) - Vimarsana News

Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates - Nevro (NYSE:NVRO)

Pain management company Nevro Corp (NASDAQ: NVRO) reported Q2 FY23 revenue of $108.8 million, up 4% Y/Y, missing the management guidance of $110 million-$112 million and 

Neuronetics, Inc. (NASDAQ:STIM) Q1 2023 Earnings Call Transcript - Vimarsana News

Neuronetics, Inc. (NASDAQ:STIM) Q1 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Neuronetics First Quarter 2023 Financial and Operating Results. [Operator Instructions] As a reminder, today's program is being recorded.